Serial Number | 79212382 |
Word Mark | TOLERO PHARMACEUTICALS |
Filing Date | Wednesday, March 22, 2017 |
Status | 709 - CANCELLED - SECTION 71 |
Status Date | Friday, January 17, 2025 |
Registration Number | 5505386 |
Registration Date | Tuesday, July 3, 2018 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 17, 2018 |
Goods and Services | Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous system, namely, diseases of the brain, movement, ocular motility and spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy and Parkinson's disease and central nervous systems infections; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the peripheral nervous system, namely, amyotrophic lateral sclerosis, numbness, lightheadedness, dysuria and dyshidrosis; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the urogenital system, namely, urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the cardiovascular system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the endocrine system, namely, growth and thyroid disorders; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the metabolic system, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the renal system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the gastroenterological system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the ophthalmologic system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the dermatologic system, namely, dermatitis, eczema, psoriasis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseases; pharmaceutical preparations for the prevention and treatment of psychiatric disorders and diseases, namely, anxiety disorders, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Parkinson's disease, Alzheimer's disease, cerebral palsy, multiple sclerosis and seizures; pharmaceutical preparations for the prevention and treatment of allergic disorders and diseases and disorders and diseases of the immune system, namely, autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of connective tissue and joints, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures and cartilage injuries; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for use in chemotherapy |
Goods and Services | Providing medical information |
NOT AVAILABLE | "PHARMACEUTICALS" |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, January 17, 2025 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, January 17, 2025 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Sumitomo Dainippon Pharma Co., Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Osaka 541-0045 JP |
Party Name | Sumitomo Dainippon Pharma Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Osaka 541-0045 JP |
Party Name | Sumitomo Dainippon Pharma Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Osaka 541-0045 JP |
Event Date | Event Description |
Saturday, August 12, 2017 | REFUSAL PROCESSED BY IB |
Thursday, July 13, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, July 14, 2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Wednesday, July 19, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, July 19, 2017 | ASSIGNED TO EXAMINER |
Thursday, July 20, 2017 | NON-FINAL ACTION WRITTEN |
Friday, July 21, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, July 25, 2017 | APPLICATION FILING RECEIPT MAILED |
Thursday, July 27, 2017 | REFUSAL PROCESSED BY MPU |
Thursday, July 27, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, March 13, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, November 8, 2017 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, November 8, 2017 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, December 7, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, December 15, 2017 | ASSIGNED TO LIE |
Tuesday, December 19, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, December 19, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, December 22, 2017 | NON-FINAL ACTION WRITTEN |
Friday, December 22, 2017 | NON-FINAL ACTION E-MAILED |
Friday, December 22, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, March 13, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, March 14, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, March 28, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, March 28, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, March 28, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Tuesday, April 17, 2018 | PUBLISHED FOR OPPOSITION |
Tuesday, April 17, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 3, 2018 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, October 3, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Thursday, October 4, 2018 | FINAL DISPOSITION PROCESSED |
Thursday, March 15, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, April 13, 2018 | NOTIFICATION PROCESSED BY IB |
Monday, July 3, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Friday, January 17, 2025 | CANCELLED SECTION 71 |
Thursday, October 4, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, October 26, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |